Xenon Pharmaceuticals, Inc. (XENE)
54.17
+0.05
(+0.09%)
USD |
NASDAQ |
May 22, 16:00
54.16
-0.01
(-0.02%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash from Investing (Quarterly) : -407.28M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | -18.08M |
| Alkermes Plc | -2.077B |
| Edesa Biotech, Inc. | 0.00 |
| ProMIS Neurosciences, Inc. | 0.00 |
| Tyra Biosciences, Inc. | -120.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -88.90M |
| Cash from Financing (Quarterly) | 843.01M |
| Free Cash Flow | -307.84M |
| Free Cash Flow Per Share (Quarterly) | -1.019 |
| Free Cash Flow to Equity (Quarterly) | -88.58M |
| Free Cash Flow to Firm (Quarterly) | -89.03M |
| Free Cash Flow Yield | -6.98% |